Revolutionary $212M Rain tokens acquisition by Nasdaq biopharma giant signals crypto mainstream breakthrough
In a stunning move that signals growing institutional confidence in cryptocurrency, Nasdaq-listed biopharmaceutical company Enlivex has announced plans to purchase $212 million worth.
